NCT00986661: A Study to Assess PV-10 Chemoablation of Cancer of the Liver

NCT00986661
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 1
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older ¬† (Adult, Older Adult)
Location of Metastases: Liver
Additional Notes: Patients must have at least one target lesion that can receive an injection
Exclusions: 
https://ClinicalTrials.gov/show/NCT00986661

Comments are closed.

Up ↑